Status:
COMPLETED
Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1
Lead Sponsor:
Ankara University
Conditions:
Complex Regional Pain Syndrome Type I
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
CRPS Type 1 can occur after traumas, surgical applications or central nervous system disorders. The triggering factor in CRPS type 1 is fracture in about half of the cases. Mirror therapy is an innova...
Detailed Description
This study is planned as a prospective randomized single blind controlled study. It was approved by the Ankara University Faculty of Medicine Ethics Committee and was conducted in accordance with the ...
Eligibility Criteria
Inclusion
- Adult individuals over 18 years of age
- CRPS type 1 diagnosis according to 2003 Budapest diagnostic criteria
- Patients who developed CRPS Type 1 due to traumatic causes (surgical procedures, fractures, immobilization)
- Patients who agree to participate in the study and sign the informed consent form
Exclusion
- Patients with peripheral nerve injuries (those with a diagnosis of CRPS type 2 according to Budapest criteria)
- Patients with CRPS Type 1 after central nervous system injury (stroke)
- Patients in the acute and post-acute rehabilitation who have had primary or secondary tendon repair of the hand
- The presence of comorbid conditions (e.g. decompensated heart failure, chronic renal insufficiency, malignancy) that would impair the functioning of the person and the health-related quality of life
- The presence of comorbid disease affecting hand function (e.g. rheumatoid arthritis, psoriatic arthritis or other inflammatory diseases that cause hand involvement)
- Patients with acute deep venous thrombosis and arterial thrombosis of the upper extremity
- Patients with arterial / venous injury and / or undergoing arterial revascularization
- Patients with excessive alcohol and inappropriate opioid use
- Patients with untreated psychiatric problems (major depression, anxiety, schizophrenia, etc.)
- Patients with recurrent CRPS Type 1
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03377504
Start Date
March 1 2017
End Date
January 31 2020
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University Faculty of Medicine, İbn-i Sina Research and Application Hospital
Ankara, Turkey (Türkiye), 06030